{
    "nctId": "NCT03183050",
    "briefTitle": "MEND 2: Making Treatment Decisions Using Genomic Testing",
    "officialTitle": "MEND 2: Making Treatment Decisions Using Genomic Testing",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Female",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 80,
    "primaryOutcomeMeasure": "Comprehension of disease characteristics as assessed by a scale",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women aged 40-75 who receive Oncotype DX testing are eligible.\n\nExclusion Criteria:\n\n* Cognitive impairment that precludes informed consent and inability to converse in English given the focus on communication in this study. Clinical communication between providers and patients with limited English proficiency is beyond the scope of this work.",
    "sex": "FEMALE",
    "minimumAge": "40 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}